ALACHUA, Fla.--()--AxoGen, Inc. (OTCBB: AXGN) today announced that it will be presenting at the Craig-Hallum 3rd Annual Alpha Select Conference to be held at Sentry Centers in New York City. Greg Freitag, AxoGen’s Chief Financial Officer will give a Company presentation on Thursday, September 27, 2012, at 12:10 PM Eastern Time.
A live audio broadcast of the AxoGen conference presentation will be available on the Company's website, www.axogeninc.com. Following the presentation, a replay will also be available through the Company's website.
About AxoGen, Inc.
AxoGen (OTCBB: AXGN) is a regenerative medicine company dedicated to advancing the science of peripheral nerve repair and commercializing next generation surgical technologies. The Company’s portfolio of proprietary products and technologies offers new options for surgical nerve repair and reconstruction. AxoGen’s products offer a full suite of surgical nerve repair solutions including Avance® Nerve Graft, the only commercially available processed nerve allograft for bridging nerve discontinuities of 5mm to 70mm in length, AxoGuard® Nerve Connector, a coaptation aid allowing for close approximation of severed nerves gaps, and AxoGuard® Nerve Protector, a bioscaffold used to reinforce a coaptation site, wrap a partially severed nerve or isolate and protect nerve tissue. For more information, visit our website at www.axogeninc.com.